EFIS Vaccine Task Force Panel
Date and time: Friday September 3, 13.15 – 14.15 (CET)
Title: The EFIS Vaccine Task Force: Challenges and opportunities for vaccine uptake across Europe
Doug Brown (British Society for Immunology)
Ursula Wiedermann-Schmidt (Austrian Society of Allergology and Immunology)
Aurelija Zvirbliene (Lithuanian Society of Immunology)
Felix Wensveen (Croatian Immunological Society)
Peter Openshaw (Imperial College, London)
Anne Spurkland (Scandinavian Society for Immunology)
The EFIS Vaccine Task Force was established in February 2020 to pool resources and expertise across European immunology to play a key role in reversing the downward trend in childhood vaccination rates as well as other vaccination programmes by providing a strong, engaging, evidence-based and collective voice. Much of the work to date has focused on increasing public confidence in COVID-19 vaccines across Europe in the wake of the pandemic.
In this panel discussion, members of the EFIS Vaccine Task Force will examine the main challenges that Europe has faced with vaccine rollout programmes during the pandemic, including the effectiveness of efforts to engage the public. Panellists will summarise experiences from their home countries before identifying some of the effective solutions and future opportunities to the challenges of vaccine engagement in Europe. This discussion will highlight the impact that the EFIS Vaccine Task Force could have in a united European effort to engage with the public about vaccination.
The long-term aim of the Task Force is to provide an expert view on vaccination issues, continue to share best practice across Europe in engaging the public and professionals in the importance and value of COVID-19 vaccination, and to build on the Task Force’s pandemic-focused work to embed the importance of vaccine engagement more widely across European populations.